Citation Impact
Citing Papers
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
Cryptochrome, Circadian Cycle, Cell Cycle Checkpoints, and Cancer
2005 StandoutNobel
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
1997 Standout
Mdm2 promotes the rapid degradation of p53
1997 StandoutNature
p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer.
1998
Inflammation and cancer
2002 StandoutNature
Gene Therapy Progress and Prospects: Development of improved lentiviral and retroviral vectors – design, biosafety, and production
2005
β-Arrestin Is Crucial for Ubiquitination and Down-regulation of the Insulin-like Growth Factor-1 Receptor by Acting as Adaptor for the MDM2 E3 Ligase
2005 StandoutNobel
p53 in growth control and neoplasia
1996
Clinical translation of angiogenesis inhibitors
2002 Standout
Insulin and related factors in premenopausal breast cancer risk
1998
Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner
2000
DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2
1997 Standout
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
2000
Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms
2004
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
2001 Standout
Targeting innate sensing in the tumor microenvironment to improve immunotherapy
2019
Regulation of the G2/M transition by p53
2001 Standout
Is p53 Involved in Tissue‐Specific Insulin Resistance Formation?
2017
The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein
2001
The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
2002 Standout
Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer
2001
To repress or not to repress: This is the guardian's question
2011
p53 Represses CAAT Enhancer-binding Protein (C/EBP)-dependent Transcription of the Albumin Gene
1999
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Cellular response to oxidative stress: Signaling for suicide and survival*
2002 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Target cell movement in tumor and cardiovascular diseases based on the epithelial–mesenchymal transition concept
2011
p53 Negatively Regulates cdc2 Transcription via the CCAAT-binding NF-Y Transcription Factor
1999
p21 in cancer: intricate networks and multiple activities
2009 Standout
The IGF-I receptor in cell growth, transformation and apoptosis
1997
Serine/Threonine Protein Phosphatase Type 5 Acts Upstream of p53 to Regulate the Induction of p21WAF1/Cip1 and Mediate Growth Arrest
1998
Microfluidic organs-on-chips
2014 Standout
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
2002
Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in mice
2019
p53 Regulates Insulin-Like Growth Factor-I (IGF-I) Receptor Expression and IGF-I-Induced Tyrosine Phosphorylation in an Osteosarcoma Cell Line: Interaction between p53 and Sp1
1998
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
1997
Inflammation and cancer: back to Virchow?
2001 Standout
EMT: 2016
2016 Standout
Effect of the Methoxychlor Metabolite HPTE on the Rat Ovarian Granulosa Cell Transcriptome In Vitro
2009
Hallmarks of Cellular Senescence
2018 Standout
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
2011
Traumatic spinal cord injury
2017 Standout
Regulation ofp53downstream genes
1998
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
2000
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
1987 StandoutNature
The IGF system and breast cancer.
2001
Negative control elements of the cell cycle in human tumors
1998 StandoutNobel
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond
2012
Congenital coronary artery anomalies: a bridge from embryology to anatomy and pathophysiology—a position statement of the development, anatomy, and pathology ESC Working Group
2016
Regulation of the human AP-endonuclease (APE1/Ref-1) expression by the tumor suppressor p53 in response to DNA damage
2008
A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
2005 Standout
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Genome Regulation by Long Noncoding RNAs
2012 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
2011 Standout
Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells.
2000
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Histone deacetylases (HDACs): characterization of the classical HDAC family
2003 Standout
Hoxa11 Regulates Stromal Cell Death and Proliferation during Neonatal Uterine Development
2003 StandoutNobel
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
1983 Standout
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
2017
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
MDM2 Suppresses p73 Function without Promoting p73 Degradation
1999 StandoutNobel
Signaling During Epicardium and Coronary Vessel Development
2011
Transcriptional control of human p53-regulated genes
2008 Standout
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
The Insulin-Like Growth Factor I Receptor as a Physiologically Relevant Target of p53 in Apoptosis Caused by Interleukin-3 Withdrawal
1997
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
1997 Standout
Surfing the p53 network
2000 StandoutNature
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
2009
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Fasting glucose is a risk factor for breast cancer: a prospective study.
2002
HLA and Disease 1982 ‐ A Survey
1983
Transcriptional regulation of human insulin receptor gene by the high‐mobility group protein HMGI(Y)
2001
Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip
2013
Cell Transplantation for Spinal Cord Injury: A Systematic Review
2013
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
2007
Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53
1996
Works of Bryan E. Strauss being referenced
Survival and Neuronal Differentiation of Mesenchymal Stem Cells Transplanted into the Rodent Brain Are Dependent upon Microenvironment
2010
Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways
2011
Functional Expression of Human p21WAF1/CIP1Gene in Rat Glioma Cells Suppresses Tumor Growthin Vivoand Induces Radiosensitivity
1997
The MDR1 Downstream Promoter Contains Sequence-Specific Binding Sites for Wild-Type p53
1995
Exploration of critical parameters for transient retrovirus production
2003
Retroviral transfer of the p16INK4a cDNA inhibits C6 glioma formation in Wistar rats
2002
Restoration of Growth Arrest by p16INK4, p21WAF1, pRB, and p53 Is Dependent on the Integrity of the Endogenous Cell-Cycle Control Pathways in Human Glioblastoma Cell Lines
1998
Genes up- and down-regulated by dermcidin in breast cancer: a microarray analysis
2008
The Region 3′ to the Major Transcriptional Start Site of the MDR1 Downstream Promoter Mediates Activation by a Subset of Mutant P53 Proteins
1995
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
2017
Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
1996
HLA‐B7 on human red blood cells. Improved detection by a radioactive anti‐IgG test*
1982
Retinoic Acid and VEGF Delay Smooth Muscle Relative to Endothelial Differentiation to Coordinate Inner and Outer Coronary Vessel Wall Morphogenesis
2010